Cell-based therapies have been making great advances toward clinical reality. Despite the increase in trial activity, few therapies have successfully navigated late-phase clinical trials and received market authorization. One possible explanation for this is that additional tools and technologies to enable their ...
Options for Imaging Cellular Therapeutics In Vivo: A Multi-Stakeholder Perspective
Cytotherapy, 2021